Chemoinformaics analysis of Dihydrocarveol-Acetate
| Molecular Weight | 196.29 | nRot | 2 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 8 |
| Exact Molecular Weight | 196.146 | nRing | 1 |
| Solubility: LogS | -3.182 | nHRing | 0 |
| Solubility: LogP | 3.2 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 34.9799 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.501 |
| Synth | 3.464 |
| Natural Product Likeliness | 2.035 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.012 |
| CACO-2 | -4.458 |
| MDCK | 0.0000239 |
| BBB | 0.99 |
| PPB | 0.551404 |
| VDSS | 1.372 |
| FU | 0.400914 |
| CYP1A2-inh | 0.055 |
| CYP1A2-sub | 0.125 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.877 |
| CYP2c9-inh | 0.021 |
| CYP2c9-sub | 0.774 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.762 |
| CYP3a4-inh | 0.169 |
| CYP3a4-sub | 0.375 |
| CL | 5.97 |
| T12 | 0.361 |
| hERG | 0.012 |
| Ames | 0.023 |
| ROA | 0.014 |
| SkinSen | 0.281 |
| Carcinogencity | 0.608 |
| EI | 0.853 |
| Respiratory | 0.532 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.535458 |